Johnson & Johnson (NYSE:JNJ) and Eli Lilly (NYSE:LLY) are utilizing Nvidia (NVDA) technology to either enhance their products ...

The Chengdu J-10 and the Lockheed Martin F-16 represent the pinnacle of fourth-generation fighter technology from China and ...

Johnson & Johnson's Tremfya is the first IL-23 inhibitor to gain FDA approval in a paediatric population for plaque psoriasis.

J&J will now explore Rybrevant's efficacy and safety in a Phase III trial in first-line, EGFR-driven HNSCC and colorectal ...

Summary and Key Points: The Chengdu J-20 Mighty Dragon, China’s first fifth-generation stealth fighter, has raised suspicions of incorporating American technology. -Following its 2011 debut, questions ...

J-Power announced an investment in US-based perovskite solar specialist Active Surfaces, along with plans to pilot product ...

Experts have recently warned that the PLAAF 5th gen fighter, thanks to the espionage efforts, is more advanced than it otherwise would be. But the real question is: has China been able to catch up?

Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business.

TROY, Mich.: 9 Feb. 2023 — The J.D. Power 2023 U.S. Vehicle Dependability Study SM (VDS), released today, reports an industry average of 186 problems per 100 (PP100) vehicles, an improvement of 6 ...

One of the largest carriers in the trucking industry has partnered to create a new logistics and freight-focused lab that aims to launch startups that solve industry challenges. J.B. Hunt Transport ...